PODD : Summary for Insulet Corporation - Yahoo Finance

U.S. Markets closed

Insulet Corporation (PODD)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
44.23+0.37 (+0.84%)
At close: 4:00PM EDT

44.23 0.00 (0.00%)
After hours: 4:43PM EDT

People also watch
DXCMNXTMNUVAHTWRWMGI
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close43.86
Open43.92
Bid23.09 x 100
Ask45.19 x 100
Day's Range43.76 - 44.46
52 Week Range26.50 - 48.23
Volume890,730
Avg. Volume443,303
Market Cap2.56B
Beta2.04
PE Ratio (TTM)-87.76
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Insulet Corp. breached its 50 day moving average in a Bullish Manner : PODD-US : April 27, 2017
    Capital Cube10 hours ago

    Insulet Corp. breached its 50 day moving average in a Bullish Manner : PODD-US : April 27, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Insulet Corp.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average ... Read more (Read more...)

  • Is Medtronic's Artificial Pancreas the Next Big Thing in Diabetes?
    Motley Fool14 days ago

    Is Medtronic's Artificial Pancreas the Next Big Thing in Diabetes?

    Medtronic's MiniMed 670G could reduce the burden on Type 1 diabetes patients, as well as slow diabetes progression by keeping blood glucose levels on target.

  • American City Business Journals17 days ago

    ​Medical device firm Insulet opening manufacturing site in Acton

    Billerica-based Medical device firm Insulet Corp. will soon break ground on a new manufacturing facility in Acton and could move its headquarters there in the future, a spokeswoman said. Insulet (PODD), which moved its headquarters from Bedford to Billerica in 2014, purchased the 195,000 square foot facility in December 2016 for $9.3 million as part of a plan to start manufacturing in the U.S. for the first time in addition to China, where its Omnipod insulin pumps are currently made by contractors.